CD8A and cancer: It has been further demonstrated that checkpoint blockade results in the reinvigoration of the CD8 T cell response by effectively acting upon the Tcf1+ population in the context of both chronic viral infections and cancer (8, 13), further stressing the importance of this T cell subset.